Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: Four-year randomized study
- 31 July 1995
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 99 (1) , 36-42
- https://doi.org/10.1016/s0002-9343(99)80102-8
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Cortical osteoclasts are less sensitive to etidronate than trabecular osteoclastsJournal of Bone and Mineral Research, 1991
- Estrogen and diphosphonate treatment provide long-term protection against osteopenia in ovariectomized ratsJournal of Bone and Mineral Research, 1991
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- Effects of ethane-1 hydroxy-1, 1-Diphosphonate (5 mg/kg/day dose) onquantitative bone histology in paget's disease of boneMetabolic Bone Disease and Related Research, 1981
- BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPYThe Lancet, 1981
- BONE RESPONSE TO TERMINATION OF ŒSTROGEN TREATMENTThe Lancet, 1978
- Activities of bone and liver alkaline phosphatases in serum in health and diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1977
- Non-linear bone loss in oophorectomized womenThe British Journal of Radiology, 1977
- Tetracycline-based histological analysis of bone remodelingCalcified Tissue International, 1969